CLINICAL_TRIALS
trial_result
· 2025-02-03
Clinical Trial Update: Efficacy and Tolerability of DITROPAN XL (Oxybutynin Chloride) Versus DETROL LA (Tolterodine Tartrate) in Treatment of Overactive Bladder [Phase 3]
Summary
Phase 3 trial comparing Ditropan XL (oxybutynin chloride) to Detrol LA (tolterodine tartrate) for overactive bladder, reporting efficacy and tolerability. The s…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Alza Corporation, DE, USA | Conditions: Urinary Incontinence | Phase 3 | Status: COMPLETED